Similarly, in another mouse model of arthritis (in SKG mice), GM-CSF treatment increased the production of IL-1β or IL-6 by macrophages and promoted the differentiation and augmentation of CD4+ T cells that produce IL-17 and GM-CSF. The gene discussed is CSF2; the disease is arthritic joint disease.